IDEAYA Biosciences (IDYA) Competitors $21.92 +0.80 (+3.79%) Closing price 07/2/2025 04:00 PM EasternExtended Trading$21.92 +0.00 (+0.02%) As of 07/2/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IDYA vs. ELAN, RVMD, LEGN, GRFS, TGTX, LNTH, NUVL, TLX, AXSM, and ADMAShould you be buying IDEAYA Biosciences stock or one of its competitors? The main competitors of IDEAYA Biosciences include Elanco Animal Health (ELAN), Revolution Medicines (RVMD), Legend Biotech (LEGN), Grifols (GRFS), TG Therapeutics (TGTX), Lantheus (LNTH), Nuvalent (NUVL), Telix Pharmaceuticals (TLX), Axsome Therapeutics (AXSM), and ADMA Biologics (ADMA). These companies are all part of the "pharmaceutical products" industry. IDEAYA Biosciences vs. Its Competitors Elanco Animal Health Revolution Medicines Legend Biotech Grifols TG Therapeutics Lantheus Nuvalent Telix Pharmaceuticals Axsome Therapeutics ADMA Biologics Elanco Animal Health (NYSE:ELAN) and IDEAYA Biosciences (NASDAQ:IDYA) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk, media sentiment and earnings. Do institutionals and insiders hold more shares of ELAN or IDYA? 97.5% of Elanco Animal Health shares are held by institutional investors. Comparatively, 98.3% of IDEAYA Biosciences shares are held by institutional investors. 0.9% of Elanco Animal Health shares are held by insiders. Comparatively, 2.5% of IDEAYA Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is ELAN or IDYA more profitable? Elanco Animal Health has a net margin of 8.43% compared to IDEAYA Biosciences' net margin of 0.00%. Elanco Animal Health's return on equity of 7.54% beat IDEAYA Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Elanco Animal Health8.43% 7.54% 3.57% IDEAYA Biosciences N/A -29.28%-27.68% Which has more risk and volatility, ELAN or IDYA? Elanco Animal Health has a beta of 1.67, suggesting that its stock price is 67% more volatile than the S&P 500. Comparatively, IDEAYA Biosciences has a beta of 0.03, suggesting that its stock price is 97% less volatile than the S&P 500. Do analysts rate ELAN or IDYA? Elanco Animal Health presently has a consensus target price of $15.33, suggesting a potential upside of 4.10%. IDEAYA Biosciences has a consensus target price of $53.42, suggesting a potential upside of 143.69%. Given IDEAYA Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe IDEAYA Biosciences is more favorable than Elanco Animal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Elanco Animal Health 0 Sell rating(s) 4 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50IDEAYA Biosciences 0 Sell rating(s) 2 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.93 Does the media refer more to ELAN or IDYA? In the previous week, Elanco Animal Health had 10 more articles in the media than IDEAYA Biosciences. MarketBeat recorded 17 mentions for Elanco Animal Health and 7 mentions for IDEAYA Biosciences. IDEAYA Biosciences' average media sentiment score of 0.50 beat Elanco Animal Health's score of 0.47 indicating that IDEAYA Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elanco Animal Health 3 Very Positive mention(s) 1 Positive mention(s) 11 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral IDEAYA Biosciences 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger earnings and valuation, ELAN or IDYA? Elanco Animal Health has higher revenue and earnings than IDEAYA Biosciences. IDEAYA Biosciences is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElanco Animal Health$4.44B1.65$338M$0.7419.91IDEAYA Biosciences$7M274.25-$274.48M-$3.59-6.11 SummaryElanco Animal Health beats IDEAYA Biosciences on 9 of the 17 factors compared between the two stocks. Get IDEAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IDYA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IDYA vs. The Competition Export to ExcelMetricIDEAYA BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.85B$2.88B$5.54B$8.87BDividend YieldN/A2.64%5.39%4.10%P/E Ratio-6.1121.3126.1919.90Price / Sales274.25278.47414.04113.66Price / CashN/A41.4736.1356.90Price / Book1.797.518.025.38Net Income-$274.48M-$55.05M$3.15B$248.50M7 Day Performance-1.66%2.07%1.48%2.06%1 Month Performance1.29%4.84%3.67%4.86%1 Year Performance-34.15%5.37%34.68%20.24% IDEAYA Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IDYAIDEAYA Biosciences3.6713 of 5 stars$21.92+3.8%$53.42+143.7%-35.0%$1.85B$7M-6.1180ELANElanco Animal Health2.3429 of 5 stars$14.29flat$15.17+6.1%+5.1%$7.10B$4.44B19.319,000Analyst ForecastRVMDRevolution Medicines4.4993 of 5 stars$36.79-0.3%$67.58+83.7%-0.5%$6.85B$11.58M-9.20250Analyst RevisionLEGNLegend Biotech3.4951 of 5 stars$35.49+2.5%$76.20+114.7%-19.7%$6.52B$627.24M-60.152,609News CoveragePositive NewsAnalyst ForecastGRFSGrifols4.137 of 5 stars$9.04+2.0%$10.30+13.9%+40.2%$6.22B$7.81B7.7323,822TGTXTG Therapeutics3.7706 of 5 stars$35.99-2.0%$40.80+13.4%+98.2%$5.71B$386.39M149.96290LNTHLantheus4.4515 of 5 stars$81.86+0.5%$130.50+59.4%+1.4%$5.66B$1.53B23.26700Positive NewsNUVLNuvalent3.736 of 5 stars$76.30-4.2%$119.60+56.7%+10.3%$5.48BN/A-17.3840Analyst UpgradeInsider TradeTLXTelix PharmaceuticalsN/A$16.07+0.4%$22.00+36.9%N/A$5.44B$516.72M0.00N/AGap DownAXSMAxsome Therapeutics4.6788 of 5 stars$104.39+1.0%$172.33+65.1%+31.6%$5.14B$432.16M-18.09380Analyst RevisionADMAADMA Biologics4.1061 of 5 stars$18.21+0.3%$27.67+51.9%+59.1%$4.35B$426.45M21.42530 Related Companies and Tools Related Companies Elanco Animal Health Alternatives Revolution Medicines Alternatives Legend Biotech Alternatives Grifols Alternatives TG Therapeutics Alternatives Lantheus Alternatives Nuvalent Alternatives Telix Pharmaceuticals Alternatives Axsome Therapeutics Alternatives ADMA Biologics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IDYA) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDYA Stock Alerts